A critically underexplored dimension, multi‐target drug discovery, is systematically examined, focusing on the design of dual‐pharmacophore inhibitors that simultaneously engage NDH‐2 and cytochrome bd oxidase, thereby raising the genetic barrier to resistance.
Said Moshawih, Anguraj Moulishankar, Chee-Yan Choo et al.· Chemical Biology and Drug De...· 0 citations
The reviewed evidence indicates that AuNPs are particularly suited to photothermal and photodynamic therapies because their plasmonic properties enable localized light-mediated effects, whereas AgNPs exhibit prominent cytotoxic activity associated with reactive oxygen species generation and modulation of the tumour mic...
Aishani Vadi, A. Jahan, Urushi Rehman et al.· Journal of drug targeting (P...· 0 citations
Breast cancer remains one of the foremost causes of cancer‐related mortality among women worldwide, where survival outcomes are strongly dictated by the timeliness and precision of diagnosis. In this review, we present gold nanomaterial‐driven biosensors as a transformative frontier in ultrasensitive breast cancer dete...
A. Pawar, Muskan Leharwani, D. Bukhary et al.· Advanced Sensor Research· 0 citations
This review highlights recent progress in the design and application of stimuli-responsive MSNs for cancer therapy, with particular emphasis on mechanisms of intracellular uptake, factors influencing cellular internalization, and strategies for controlled drug release.
U. Abbasi, Md. Saifuddin, Mahak Fatima et al.· Journal of drug targeting (P...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.